TLP Sequenced and Studied for Its Functions with Targets Diagnostic and Therapeutic: Recent Perspective

  • Giulio Tarro Beaumont Bonelli Foundation for Cancer Research, Naples, Italy and Committee on Biotechnologies and Virus Sphere, World Academy of Biomedical Technologies, UNESCO, Paris, France.
Keywords: TLP, NSCL cancer, vaccine

Abstract

From the first analysis of immuneprecipitation followed by Western Blotting (WB) Corin and TLP seem to precipitate at the same height (approximately 50 KDa) and are recognized by the same antibodies. In parallel the tests of immunoprecipitation by the use of cell extracts derived from lung cancer cells A549 and NCI-H23 are improved with the aim to be able of obtaining a precipitate containing only the TLP. In fact the partial aminoacid sequence of TLP showes a high homology with the sequence of human Corin (only one aminoacid is different) and is present in lung cancer under different isoforms. It is known that human Corin is expressed mostly outside the cells and the protein extract derived from the extracellular medium and from the cells transfected with the plasmid, which overexpresses Corin, showes many more bands analyzed on SDS-PAGE that are equivalent to the bands (about 50-100 KDa) observed in the WB analyzed with anti-TLP.

Published
2020-04-03
How to Cite
Tarro, G. (2020). TLP Sequenced and Studied for Its Functions with Targets Diagnostic and Therapeutic: Recent Perspective. Innovations in Medicine and Medical Research Vol. 2, 129-133. Retrieved from https://stm1.bookpi.org/index.php/immr-v2/article/view/1219